Idexx Laboratories Inc (IDXX)
Idexx Laboratories Inc is a global provider of veterinary diagnostics, software, and services for animal health. The company develops testing solutions to help veterinarians diagnose and monitor health conditions in animals, including in-clinic diagnostic instruments, laboratory diagnostic services, and veterinarian practice management software. Founded in 1983, Idexx has established itself as a leading innovator in veterinary medical diagnostics and animal health solutions.
Company News
Five S&P 500 stocks outperformed in August 2025, including Albemarle, UnitedHealth Group, Intel, Humana, and Idexx Laboratories, each with unique factors driving their stock price increases.
The veterinary oncology market is projected to grow from $1.84 billion in 2025 to $3.55 billion by 2030, driven by technological advances, rising pet ownership, and increasing demand for advanced cancer treatments in veterinary medicine.
IDEXX Laboratories reported strong Q2 2025 earnings, with $3.50 per share beating estimates and revenue rising 11% to $1.11 billion, driven by robust Companion Animal Group sales. The company raised full-year guidance, reflecting strong performance in pet healthcare.
IDEXX's (IDXX) supply chain operations bear the brunt of geopolitical instability, including the current war in Ukraine.
